RxDoctor Payments Data

Julie Brennan

Women's Health · Youngstown, OHNPI 1447362850

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $413 and has fallen 73.9% since, to $108 in 2025.

$1,256in general payments, 2019–2025

Across 71 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mayne Pharma Commercial LLC$203
  • Sumitomo Pharma America, Inc.$172
  • Evofem Biosciences, Inc.$129
  • AbbVie$123
  • Pfizer$106
  • Agile Therapeutics, Inc.$78
  • plus $446 from 13 others

What the payments were for

  • Food & beverage$1,256100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,256 in reported general payments places this provider in the 80th percentile of 333 women's health providers in Ohio.

See all women's health providers in Ohio

Medicare billing

Part B allowed, 2024
$71,413
Medicare patients
331
Services billed
1,769

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol108$8,049
Ibandronate Sodium58$1,523
Clobetasol Propionate48$1,315
Alendronate Sodium100$544
ValacyclovirValacyclovir Hcl16$418
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip46$398
Metronidazole12$391
Triamcinolone Acetonide42$204
Medroxyprogesterone Acetate11$183
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst16$139
Fluconazole29$72

Paid to pharmacies, not to this prescriber.

Other women's health in Youngstown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →